David M. Gershenson

No ORCID on file · 9 papers in corpus · active 1989-2024

Study types

  • article 6
  • other 2

Condition tags

  • endometriosis 5
  • adenomyosis 1
other 2024
Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers
Clinical cancer research : an official journal of the American Association for Cancer Research ·doi:10.1158/1078-0432.CCR-23-2819

PURPOSE: We aimed to describe RAS mutations in gynecologic cancers as they relate to clinicopathologic and genomic features, survival, and therapeutic implications. EXPERIMENTAL DESIGN: Gynecologic cancers with available somatic molecular …

2018
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001).
Gynecologic Oncology ·doi:10.1016/j.ygyno.2018.04.572

ObjectiveTo evaluate the efficacy and tolerability of cabozantinib in recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer.MethodsPatients with recurrent ovarian, fallopian or primary peritoneal tumors with at least 50%…

other 2015
Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology ·doi:10.1200/JCO.2014.58.3401

PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been docum…

article 2002
Ovarian and extraovarian endometriosis-associated cancer
Obstetrics and gynecology ·doi:10.1016/s0029-7844(02)02149-x

OBJECTIVE: To determine clinical characteristics of women with endometriosis-associated intraperitoneal cancers, to assess differences based on the relationship of the cancer to the endometriosis, and to assess factors associated with survi…

article 2002
Ovarian and Extraovarian Endometriosis-Associated Cancer
·doi:10.1097/00006250-200210000-00028

In Brief OBJECTIVE To determine clinical characteristics of women with endometriosis-associated intraperitoneal cancers, to assess differences based on the relationship of the cancer to the endometriosis, and to assess factors associated wi…

article 1995
Intraoperative lymphatic mapping for vulvar cancer
·doi:10.1016/0020-7292(95)90247-3

OBJECTIVE: To determine the feasibility of intraoperative lymphatic mapping in patients with vulvar cancer. METHODS: Isosulfan blue was injected intradermally at the junction of tumor and normal skin in nine patients. We then attempted to i…

article 1990
Endometrioid carcinoma of the ovary: Retrospective review of 145 cases
Gynecologic oncology ·doi:10.1016/0090-8258(90)90263-k

From 1967 through December 1987, 145 patients with endometrioid carcinoma of the ovary were treated at the University of Texas M. D. Anderson Cancer Center. Thirty-eight patients (26.2%) had stage I disease, 28 (19.3%) stage II, 60 (41.4%) …

article 1989
Clear cell carcinoma of the ovary: A study of 59 cases
Gynecologic oncology ·doi:10.1016/0090-8258(89)90043-7

Clear cell carcinoma of the ovary accounts for 2 to 3% of all epithelial ovarian neoplasms. Patient profiles, pathological characteristics, and results of treatment are reviewed for 59 patients. The median age was 51. Disease extent at diag…

article 1989
Endometrial Tissue in Myometrial Vessels not Associated with Menstruation
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists ·doi:10.1097/00004347-198906000-00007

The presence of endometrial tissue in myometrial vessels has been described in the literature primarily in association with the menstrual period. We reviewed 277 hysterectomy specimens to assess the frequency of endometrial tissue in myomet…